|
Table 1. Clinical trials currently underway in USA sorted by disease name and stem cell type investigated.
|
|
Disease
|
Cell type being investigated
|
|
Acute myocardial infarction
|
Autologous bone marrow-derived mesenchymal stem cells
|
|
Alzheimer’s disease
|
Adult neuronal progenitor stem cell
|
|
Corneal degeneration
|
Amniotic epithelial stem cells
|
|
Dental pulp necrosis
|
Stem cells from human exfoliated deciduous teeth
|
|
Diabetes (type 1)
|
Umbilical cord mesenchymal stem cells, hematopoietic stem cell
|
|
Heart failure
|
Human cardiac stem cells, mesenchymal stem cells, adipose derived stem cells
|
|
Kidney failure
|
Hematopoietic stem cell, autologous and allogeneic bone marrow stem cell, peripheral blood stem cell, mesenchymal stem cells
|
|
Macular degeneration (Age-related)
|
Autologous bone marrow stem cells, adipose derived stem cells
|
|
Multiple sclerosis
|
Adult neuronal progenitor stem cell, autologous mesenchymal stem cells, enriched hematopoietic stem cells, human umbilical cord mesenchymal stem cells, autologous adipose-derived mesenchymal stem cells, peripheral blood stem cell transplantation
|
|
Parkinson’s disease
|
Adult neuronal progenitor stem cell, autologous bone marrow derived stem cells, adipose-derived stem cells
|
|
Rheumatoid arthritis
|
Umbilical cord-derived mesenchymal stem cells, hematopoietic stem cell, bone marrow mesenchymal stem cell, peripheral blood stem cell
|
Source: U.S. National Institutes of Health, 2014.